TotalMarketCap

Biovie

BIVINasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$10.507 M

$1.21 -9.69%

Close of 6 Nov 2026

As of 6 Nov 2026, Biovie (BIVI) has a market capitalization of $10.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$17.5M

Loss-making

Shares outstanding

10,724,724

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Biovie lists more than one class of stock. Company figures above cover all classes combined.

BIVIW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #410Lisata TherapeuticsLSTA$10.8M
  2. #411Palatin TechnologiesPTN$10.5M
  3. #412BiovieBIVI$10.5M
  4. #413CytoMed TherapeuticsGDTC$10.4M
  5. #414Chemomab TherapeuticsCMMB$10.3M

What if Biovie were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,252,081

Per share 2,687,448× higher

Bitcoin $1.53T

$175,964.43

Per share 145,413× higher

Apple $5.02T

$577,674.80

Per share 477,378× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Biovie are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.